Back to top

Buy Rating Affirmed for Teladoc Amid Strong Quarterly Performance and Growth Potential

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Teladoc (TDOC – Research Report) and decreased the price target to $25.00 f...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Teladoc Health, Inc. (TDOC)